StockTipsArenaBeta

BUY Jubilant Pharmova Limited — Sandeep Jain, Tradeswift

BUYJubilant Pharmova Limited
Jubilant Pharmova share price target & all analyst calls

bySandeep Jain, TradeswiftHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via Zee Business (Live)

Entry₹1,074Inferred
Target₹1,150
Total upside +7.08% (call closed)
Stop loss₹1,010-5.96% risk
Exit₹1,0101 Oct 2026, 9:20 am
Stop-loss hit-5.96%
Follow Sandeep Jain for new calls(17% target hit, 83 closed calls)Get alertsWatch JUBLPHARMA for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 1 Oct 2026
0 supporting1 neutral0 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (1)

Jubilant Pharmova's US CMO facility gets 'Voluntary Action Indicated' classification

NewsCnbc-Tv18·11 Sept · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Jubilant Pharmova

All analyst calls on Jubilant Pharmova

More from Sandeep Jain, Tradeswift

Every call and its outcome